Summary
Severe acute respiratory syndrome, known as SARS, was first reported in Asia in 2003, after a Chinese-American businessman died from a mysterious illness. Soon, many of the people who had treated this man became sick with the same respiratory symptoms. SARS quickly spread across Southeast Asia and China, and caused widespread fear of a global epidemic when it reached Toronto, Canada. In all, more than 8,000 people became ill, and nearly 800 died. Although SARS was quickly contained, future outbreaks remain a threat. SARS, Third Edition traces the history of the 2003 outbreak and its aftermath, describing the life cycle of the SARS virus, how the disease is spread, and the signs and symptoms. This revised edition includes updated graphics, recent discoveries about the SARS virus, and information about the progress of a SARS vaccine.
About the Author(s)
Patrick Guilfoile earned his Ph.D. in bacteriology at the University of Wisconsin-Madison studying antibiotic resistance, followed by a postdoctoral fellowship at the Whitehead Institute for Biomedical Research at MIT, where he studied infectious disease. He then spent 21 years at Bemidji State University as a faculty member teaching microbiology, genetics, engaging in research, and serving as an administrator. This was followed by five years at the University of Wisconsin-Stout, serving as provost and interim chancellor. He has written extensively, authoring numerous papers and articles in science and science education journals, a laboratory manual, and seven books in the Deadly Diseases and Epidemics series, along with several revisions of additional titles.
Joaquima Serradell graduated with a degree in clinical pharmacy from the University of Barcelona, Spain. She also holds both a MPH and a Ph.D. in social and administrative pharmacy from the University of Minnesota. She completed a postdoctoral research fellowship at the United States Pharmacopeia and has taught and conducted research at the Philadelphia College of Pharmacy and at the Department of Medicine of the University of Pennsylvania. She is currently a consultant in the fields of pharmacoepidemiology and international aspects of health-care delivery. She has written numerous articles and book chapters on the behavioral, epidemiological, and economic aspects of drug use.